I have probably had too many whiskeys. I don't like this one which was supposed to have some sort of sherry flavoring whatever it means. My reasoning is this. The medical marijuana sector is again going to the dogs for some reason. Given where this company is and what it has with the negativity that has crept in, in my opinion the market cap should not be more than 20M. Given the MC is over 80M then a fair share price would be 80/20 of what it is now or around 7 cents. This is assuming the company will survive and be successful. Let's see what happens. I hope that I am wrong.
- Forums
- ASX - By Stock
- AC8
- News: AC8 Auscann Group Says Canopy Growth Sold Its 13.2% Interest In Co
News: AC8 Auscann Group Says Canopy Growth Sold Its 13.2% Interest In Co, page-63
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online